The explosion in the use of costly GLP-1 drugs has helped fuel a 9.3% jump in per-person drug costs for CT residents.

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

The largest healthcare stocks by market capitalization are undergoing significant sell-offs. UnitedHealth is still a large ...

The digital health market is welcoming new IPOs for the first time in years. Bankers and investors think these 9 startups ...

Dr Bryan Betty joined Jack Tame to discuss Wegovy – what it is, how you use it, the side effects, and why people are seeking medical treatment for their weight. A once-weekly injection for weight loss ...

The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in.  | Novo ...

Novo Nordisk trades at a significant discount to Eli Lilly, offering nearly 38% upside. Click here to find out why NVO stock ...

The following is a special feature from CivicScience CEO and Founder John Dick. Learn how you can turn insights like these ...

Sustainability awareness remains strong in the Middle East, with 75% of respondents expressing concern about climate change.

The Secretary of Health Services wants every American to use a wearable device in the next four years. Experts say it's a ...

The preventative healthcare measures recommended in the Scotland’s Population Health Framework 2025-2035 plan have been ...